← Back to headlines
Pfizer Identified as Potentially Underrated GLP-1 Stock
An analysis suggests that Pfizer could be an underrated stock, particularly in the context of its GLP-1 drug development.
30 Jun, 13:20 — 30 Jun, 13:20
Sources
Showing 1 of 1 sources
